Clarivate Plc (CLVT) NYSE

2.57

-0.02(-0.77%)

Updated at March 13 04:00PM

Currency In USD

Key Executives

Name	Title	Pay	Year Born
Matitiahu Shem Tov	Chief Executive Officer & Director	1.16M	1961
Henry Levy	President of Life Sciences & Healthcare	1M	1973
Gordon Samson	President of Intellectual Property	1.05M	1966
Bar Veinstein	President of Academia & Government	1.08M	1973
Jonathan Collins	Executive VP & CFO	1.25M	1980
John Doulamis	Senior VP & General Counsel	0	N/A
Mark J. Donohue	Head of Investor Relations	0	N/A
Michael Easton	Senior Vice President of Finance & Chief Accounting Officer	0	1973
William E. Graff	Executive VP & Chief Information Officer	0	N/A
Tabita Andersson	Senior Vice President of Communications & Brand	0	N/A

Name

Title

Pay

Year Born

Matitiahu Shem Tov

Chief Executive Officer & Director

1.16M

1961

Henry Levy

President of Life Sciences & Healthcare

1973

Gordon Samson

President of Intellectual Property

1.05M

1966

Bar Veinstein

President of Academia & Government

1.08M

1973

Jonathan Collins

Executive VP & CFO

1.25M

1980

John Doulamis

Senior VP & General Counsel

N/A

Mark J. Donohue

Head of Investor Relations

N/A

Michael Easton

Senior Vice President of Finance & Chief Accounting Officer

1973

William E. Graff

Executive VP & Chief Information Officer

N/A

Tabita Andersson

Senior Vice President of Communications & Brand

N/A

Description

Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.